The FAM89B antibody targets the FAM89B protein, encoded by the FAM89B gene (Family With Sequence Similarity 89 Member B), which is conserved across vertebrates but remains relatively understudied. FAM89B is a cytoplasmic protein implicated in immune regulation and cellular metabolism. Early studies suggest its potential involvement in modulating inflammatory responses, possibly through interactions with immune signaling pathways like NF-κB or MAPK. FAM89B has also been linked to metabolic processes, with altered expression observed in conditions such as obesity and type 2 diabetes.
Antibodies against FAM89B are primarily used as research tools to investigate its expression patterns, subcellular localization, and functional roles. They enable techniques like Western blotting, immunofluorescence, and immunohistochemistry, aiding in protein detection across tissues and cell lines. Some studies employ FAM89B antibodies to explore its potential as a biomarker or therapeutic target in diseases like cancer, where dysregulated FAM89B expression has been reported.
Commercial FAM89B antibodies are typically polyclonal or monoclonal, raised in hosts like rabbits or mice, and require validation via knockout controls or siRNA-mediated silencing to confirm specificity. Despite limited clinical data, ongoing research aims to clarify FAM89B's mechanistic contributions to immunity and metabolism, positioning it as a protein of growing interest in biomedical contexts.